Atlas Trials

An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder

Clinical trial NCT00415142 · COMPLETED

Trial details

NCT number
NCT00415142
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Depressive Disorder
Start date
2006-12-01
Primary completion
2008-02-01
Enrollment
393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.